Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 41-50 of 56 (Search time: 0.004 seconds).

  First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group (Journal article)

  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Journal article)

  Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up (Journal article)

  Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group (Journal article)

  Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Journal article)

  Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group (Journal article)

  Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study (Journal article)

  Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis? (Journal article)

  Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study (Journal article)

  Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence (Journal article)